A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer (ABC)

MONTEMURRO F., CHOA G., FAGGIUOLO R., DONADIO M., MINISCHETTI M., DURANDO A., CAPALDI A., VIETTI RAMUS G., ALABISO Oscar, AGLIETTA M.

Research output: Contribution to conferencePaper

Original languageEnglish
Pages48
Number of pages48
Publication statusPublished - 1 Jan 2003
Externally publishedYes
EventProc Am Soc Clin Oncol -
Duration: 1 Jan 2003 → …

Conference

ConferenceProc Am Soc Clin Oncol
Period1/01/03 → …

Cite this